Insider · CIK 0001738053

VHCP Management III, LLC

CIK 0001738053 Name as filed on the most recent filing

Filed as VHCP Management III, LLC (46)

117 transaction lines · from 46 filings · filed 2018-09-07 to 2026-03-27 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

0 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2026-03-26 S, Open-market sale KalVista Pharmaceuticals, Inc.KALV 3 lines 730,822, disposed Open Form 4 filing 0001231919-26-000286
2026-03-25 S, Open-market sale KalVista Pharmaceuticals, Inc.KALV 2 lines 2,960,326, disposed Open Form 4 filing 0001231919-26-000286
2025-04-09 P, Open-market purchase KalVista Pharmaceuticals, Inc.KALV 235,500, acquired Open Form 4 filing 0001415889-25-010587
2025-02-14 P, Open-market purchase Oruka Therapeutics, Inc.ORKA 1,015,803, acquired Open Form 4 filing 0001415889-25-005908
2025-02-13 P, Open-market purchase KalVista Pharmaceuticals, Inc.KALV 575,661, acquired Open Form 4 filing 0001415889-25-004324
2025-02-13 P, Open-market purchase Oruka Therapeutics, Inc.ORKA 173,869, acquired Open Form 4 filing 0001415889-25-005908
2025-02-12 P, Open-market purchase KalVista Pharmaceuticals, Inc.KALV 923,000, acquired Open Form 4 filing 0001415889-25-004324
2025-02-12 P, Open-market purchase Oruka Therapeutics, Inc.ORKA 106,396, acquired Open Form 4 filing 0001415889-25-005908
2025-02-11 P, Open-market purchase KalVista Pharmaceuticals, Inc.KALV 245,134, acquired Open Form 4 filing 0001415889-25-003665
2025-02-11 P, Open-market purchase Oruka Therapeutics, Inc.ORKA 105,043, acquired Open Form 4 filing 0001415889-25-005908
2025-02-10 P, Open-market purchase KalVista Pharmaceuticals, Inc.KALV 37,812, acquired Open Form 4 filing 0001415889-25-003665
2025-02-10 P, Open-market purchase Oruka Therapeutics, Inc.ORKA 6,257, acquired Open Form 4 filing 0001415889-25-005908
2025-02-07 P, Open-market purchase KalVista Pharmaceuticals, Inc.KALV 684,199, acquired Open Form 4 filing 0001415889-25-003665
2025-02-03 P, Open-market purchase KalVista Pharmaceuticals, Inc.KALV 134,262, acquired Open Form 4 filing 0001415889-25-002809
2025-01-31 P, Open-market purchase KalVista Pharmaceuticals, Inc.KALV 104,493, acquired Open Form 4 filing 0001415889-25-002809
2025-01-30 P, Open-market purchase KalVista Pharmaceuticals, Inc.KALV 382,873, acquired Open Form 4 filing 0001415889-25-002809
2024-02-08 P, Open-market purchase KalVista Pharmaceuticals, Inc.KALV 437,281, acquired Open Form 4 filing 0001415889-24-003118
2024-02-07 P, Open-market purchase KalVista Pharmaceuticals, Inc.KALV 754,601, acquired Open Form 4 filing 0001415889-24-003118
2024-02-06 P, Open-market purchase KalVista Pharmaceuticals, Inc.KALV 65,947, acquired Open Form 4 filing 0001415889-24-003118
2024-01-30 P, Open-market purchase KalVista Pharmaceuticals, Inc.KALV 1,274,793, acquired Open Form 4 filing 0001415889-24-002183
2024-01-29 P, Open-market purchase KalVista Pharmaceuticals, Inc.KALV 1,146,132, acquired Open Form 4 filing 0001415889-24-001941
2024-01-26 P, Open-market purchase KalVista Pharmaceuticals, Inc.KALV 54,179, acquired Open Form 4 filing 0001415889-24-001941
2024-01-25 P, Open-market purchase KalVista Pharmaceuticals, Inc.KALV 89,492, acquired Open Form 4 filing 0001415889-24-001941
2024-01-24 P, Open-market purchase KalVista Pharmaceuticals, Inc.KALV 257,334, acquired Open Form 4 filing 0001415889-24-001781
2024-01-23 P, Open-market purchase KalVista Pharmaceuticals, Inc.KALV 136,648, acquired Open Form 4 filing 0001415889-24-001781
2024-01-22 P, Open-market purchase KalVista Pharmaceuticals, Inc.KALV 847,702, acquired Open Form 4 filing 0001415889-24-001781
2024-01-19 P, Open-market purchase KalVista Pharmaceuticals, Inc.KALV 310,750, acquired Open Form 4 filing 0001209191-24-001957
2024-01-18 P, Open-market purchase KalVista Pharmaceuticals, Inc.KALV 496,397, acquired Open Form 4 filing 0001209191-24-001957
2024-01-17 P, Open-market purchase KalVista Pharmaceuticals, Inc.KALV 994,455, acquired Open Form 4 filing 0001209191-24-001957
2024-01-16 P, Open-market purchase KalVista Pharmaceuticals, Inc.KALV 249,495, acquired Open Form 4 filing 0001209191-24-001666
2024-01-11 P, Open-market purchase KalVista Pharmaceuticals, Inc.KALV 84,284, acquired Open Form 4 filing 0001209191-24-001666
2024-01-10 P, Open-market purchase KalVista Pharmaceuticals, Inc.KALV 604,359, acquired Open Form 4 filing 0001209191-24-001403
2024-01-09 P, Open-market purchase KalVista Pharmaceuticals, Inc.KALV 261,449, acquired Open Form 4 filing 0001209191-24-001403
2024-01-08 P, Open-market purchase KalVista Pharmaceuticals, Inc.KALV 860,649, acquired Open Form 4 filing 0001209191-24-001403
2024-01-04 P, Open-market purchase KalVista Pharmaceuticals, Inc.KALV 505,762, acquired Open Form 4 filing 0001209191-24-001008
2024-01-03 P, Open-market purchase KalVista Pharmaceuticals, Inc.KALV 214,781, acquired Open Form 4 filing 0001209191-24-001008
2023-12-29 P, Open-market purchase KalVista Pharmaceuticals, Inc.KALV 75,102, acquired Open Form 4 filing 0001209191-23-060015
2023-12-28 P, Open-market purchase KalVista Pharmaceuticals, Inc.KALV 5,893,625, acquired Open Form 4 filing 0001209191-23-060015
2023-12-27 P, Open-market purchase KalVista Pharmaceuticals, Inc.KALV 496,923, acquired Open Form 4 filing 0001209191-23-060015
2022-10-26 S, Open-market sale Tricida, Inc.TCDA 1,088,900, disposed Open Form 4 filing 0001209191-22-054671
2022-10-25 S, Open-market sale Tricida, Inc.TCDA 1,123,138, disposed Open Form 4 filing 0001209191-22-054671
2022-10-24 S, Open-market sale Tricida, Inc.TCDA 1,289,508, disposed Open Form 4 filing 0001209191-22-054671
2022-10-19 P, Open-market purchase Tricida, Inc.TCDA 2 lines 3,272,281, acquired Open Form 4 filing 0001209191-22-054201
2022-10-18 P, Open-market purchase Tricida, Inc.TCDA 483,992, acquired Open Form 4 filing 0001209191-22-054201
2022-10-17 P, Open-market purchase Tricida, Inc.TCDA 1,987,308, acquired Open Form 4 filing 0001209191-22-053863
2022-10-13 P, Open-market purchase Tricida, Inc.TCDA 55,995, acquired Open Form 4 filing 0001209191-22-053863

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.

How to cite this page

ebomi catalog. VHCP Management III, LLC, insider transactions. Retrieved 2026-08-23 from https://ebomi.com/insider/0001738053

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.